Stockreport

Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report
PDF Product is currently under review with the FDAPotential approval and launch mid-2026 DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Et [Read more]